// App-Quantinova.ai

POS04 : Clinical outcomes of patients with long lesions treated with everolimus-eluting bioresorbable vascular scaffolds: a subgroup analysis from a single-centre all-comers absorb registry

Researchers

Presenter

  • Camacho Freire S.J

Principal Investigators

  • Roa Garrido J

  • Cardenal Piris R

  • Gomez Menchero A.E

  • Ramzy A.M

  • Gomez Fernandez P

  • Moraleda Salas T

  • Morgado Polavieja J

  • Lopez Suarez A

  • Diaz Fernandez J.F

Medical Centers

  • Pharmacy, Hospital Juan Ramon Jimenez, Huelva, Spain

  • Benha University, Benha, Egypt

Locations

  • Spain

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Multi-vessel disease

  • Complex calcified coronary artery lesions

  • Hypertension

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved